Douglas M. Hunt - 03 Jan 2022 Form 4 Insider Report for PUMA BIOTECHNOLOGY, INC. (PBYI)

Role
The Reporting Person is the Senior Vice President of Regulatory Affairs of the Issuer.
Signature
/s/ Douglas M. Hunt
Issuer symbol
PBYI
Transactions as of
03 Jan 2022
Net transactions value
-$11,890
Form type
4
Filing time
05 Jan 2022, 17:03:24 UTC
Previous filing
06 Dec 2021
Next filing
03 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PBYI Common Stock Sale $11,890 -3,707 -5.7% $3.21 61,083 03 Jan 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.19 to $3.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

The Reporting Person is the Senior Vice President of Regulatory Affairs of the Issuer.